Your browser doesn't support javascript.
loading
Stem Cell Therapy for Treatment of Stress Urinary Incontinence: The Current Status and Challenges.
Zhou, Shukui; Zhang, Kaile; Atala, Anthony; Khoury, Oula; Murphy, Sean V; Zhao, Weixin; Fu, Qiang.
Afiliación
  • Zhou S; Department of Urology, Affiliated Sixth People's Hospital, Shanghai Jiao Tong University, Shanghai, China.
  • Zhang K; Department of Urology, Affiliated Sixth People's Hospital, Shanghai Jiao Tong University, Shanghai, China.
  • Atala A; Wake Forest Institute for Regenerative Medicine, Winston Salem, NC, USA.
  • Khoury O; Wake Forest Institute for Regenerative Medicine, Winston Salem, NC, USA.
  • Murphy SV; Wake Forest Institute for Regenerative Medicine, Winston Salem, NC, USA.
  • Zhao W; Wake Forest Institute for Regenerative Medicine, Winston Salem, NC, USA.
  • Fu Q; Department of Urology, Affiliated Sixth People's Hospital, Shanghai Jiao Tong University, Shanghai, China.
Stem Cells Int ; 2016: 7060975, 2016.
Article en En | MEDLINE | ID: mdl-26880983
Stress urinary incontinence (SUI) is a common urinary system disease that mostly affects women. Current treatments still do not solve the critical problem of urethral sphincter dysfunction. In recent years, there have been major developments in techniques to obtain, culture, and characterize autologous stem cells as well as many studies describing their applications for the treatment of SUI. In this paper, we review recent publications and clinical trials investigating the applications of several stem cell types as potential treatments for SUI and the underlying challenges of such therapy.

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Stem Cells Int Año: 2016 Tipo del documento: Article País de afiliación: China Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Stem Cells Int Año: 2016 Tipo del documento: Article País de afiliación: China Pais de publicación: Estados Unidos